MAG Optics

MAG Optics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MAG Optics is a private, pre-revenue medical device innovator developing a novel intra-corneal implant platform to treat Keratoconus and other refractive errors. Founded in 2003 and based in Rochester, NY, the company's approach aims to transform irregular corneas by applying personalized biomechanical forces, addressing a significant unmet clinical need. The technology has shown promise in early data for improving corneal regularity and alignment, and the company has gained recognition through awards and residency at Johnson & Johnson Innovation JLABS.

Ophthalmology

Technology Platform

Patient-centric corneal re-shaping platform using an intra-corneal implant designed to apply personalized, directed biomechanical forces to reshape irregular corneas, addressing conditions like Keratoconus and Presbyopia.

Opportunities

The primary opportunity is addressing the high unmet need in Keratoconus with a potentially transformative, one-time surgical solution.
A significantly larger secondary opportunity exists in applying the platform technology to the massive elective refractive market for Presbyopia and other common vision errors, which represents a multi-billion dollar global market.

Risk Factors

Key risks include clinical and regulatory failure to demonstrate safety and efficacy in trials, surgeon adoption and reimbursement challenges for the Keratoconus indication, and competition from existing and emerging corneal treatments.
The company is pre-revenue and will require substantial capital to reach commercialization.

Competitive Landscape

In Keratoconus, competition includes corneal collagen cross-linking (CXL) devices (e.g., Avedro's KXL), intracorneal ring segments (ICRS), specialized contact lenses, and corneal transplants. In the broader refractive market, competition is intense from laser vision correction (LASIK/PRK), phakic IOLs, and presbyopia-correcting IOLs from giants like Alcon, J&J Vision, and Bausch + Lomb.